The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mace Dent Johnson Mace Dent Johnson is a writer on the kitchen team. To test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results